Estonian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
viscum rotundifolium/vähk
Link salvestatakse lõikelauale
9 tulemused
Medicament containing recombinant mistletoe lectins for the treatment of brain tumors
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
CROSS-REFERENCE TO RELATED APPLICATIONS
This application is a national stage application (under 35 U.S.C. .sctn. 371) of PCT/EP2017/053429, filed Feb. 15, 2017, which claims benefit of European Application No. 16155735.0, filed Feb. 15, 2016, both of which are incorporated herein by reference in
Pharmaceutical preparations derived from European mistletoe
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention relates generally to the treatment of Acquired Immune Deficiency Syndrome (AIDS) and other diseases or conditions where an individual's immune system is suppressed. More particularly, the present invention relates to
Antiviral agent comprising recombinant mistletoe lectins
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
The invention relates to an antiviral agent comprising recombinant mistletoe lectins for treating virus infections, and to a medicinal drug and/or a pharmaceutical composition for treating virus infections.
When virus infections occur, viruses penetrate the organism, where they replicate. The
Antiviral agent comprising recombinant mistletoe lectins
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
SEQUENCE LISTING
The instant application contains a Sequence Listing which has been submitted in ASCII format via EFS-Web and is hereby incorporated by reference in its entirety. Said ASCII copy, created on Mar. 8, 2016 is named 74062_0001_01_SL_ST25.txt and is 32,885 bytes in size.
The invention
Orally ingestible preparation of mistletoe lectins and method
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
TECHNICAL FIELD
The present invention relates to medicinally useful preparations derived from mistletoe, methods for making such preparations and treatment methods employing such preparations. More specifically, the invention relates to an orally ingestible preparation of mistletoe lectins useful in
Drug containing recombinant mistletoe lectins for treating malignant melanoma
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
SEQUENCE LISTING
The instant application contains a Sequence Listing which has been submitted in ASCII format via EFS-Web and is hereby incorporated by reference in its entirety. Said ASCII copy, created on Mar. 8, 2016 is named 74062_0002_01_SL_ST25.txt and is 33,022 bytes in size.
The invention
Pharmaceutical preparations derived from korean mistletoe
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention relates generally to the treatment of Acquired Immune Deficiency Syndrome (AIDS) and other diseases or conditions where an individual's immune system is suppressed. More particularly, the present invention relates to
Mistletoe extract and method
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
FIELD OF THE INVENTION
The present invention relates generally to the preparation of mistletoe extracts and methods for making such extracts in a medicinally useful and pharmaceutically acceptable form. More particularly, the present invention relates to methods for making and using mistletoe
Crude extract from Viscum album coloratum, and proteins and lectins isolated therefrom
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
FIELD OF THE INVENTION
The present invention relates, in general, to a crude extract from Viscum album coloratum and proteins and lectins isolated therefrom. More particularly, the present invention relates to an extract from Viscum album coloratum which enhances biological immunity with antitumoral
Kõige täiuslikum ravimtaimede andmebaas, mida toetab teadus
- Töötab 55 keeles
- Taimsed ravimid, mida toetab teadus
- Maitsetaimede äratundmine pildi järgi
- Interaktiivne GPS-kaart - märgistage ürdid asukohas (varsti)
- Lugege oma otsinguga seotud teaduspublikatsioone
- Otsige ravimtaimi nende mõju järgi
- Korraldage oma huvisid ja hoidke end kursis uudisteuuringute, kliiniliste uuringute ja patentidega
Sisestage sümptom või haigus ja lugege ravimtaimede kohta, mis võivad aidata, tippige ürdi ja vaadake haigusi ja sümptomeid, mille vastu seda kasutatakse.
* Kogu teave põhineb avaldatud teaduslikel uuringutel
